Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer

British Journal of Cancer

Volumn 77, Issue 3, 1998, Pages 497-500

  Ridge, S A ^a   Sludden, J ^a   Wei, X ^b   Sapone, A ^b   Brown, O ^a   Hardy, S ^a   Canney, P ^c   Fernandez Salguero, P ^b   Gonzalez, F J ^b   Cassidy, J ^a   McLeod, H L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

5 fluorouracil; Colorectal cancer; Dihydropyrimidine dehydrogenase; Polymorphism

Indexed keywords

COMPLEMENTARY DNA; DIHYDROPYRIMIDINE DEHYDROGENASE; DNA; DRUG METABOLIZING ENZYME; FLUOROURACIL; FOLINIC ACID;

AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; DRUG TOXICITY; ENZYME ACTIVITY; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PRIORITY JOURNAL;

EID: 15144351973     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.79     Document Type: Article

References (15)

1. Beuzeboc P, Pierga J-Y, Stoppa-Lyonnet D, Etienne MC, Milano G and Pouillart P (1996) Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogensis imperfecta. Eur J Cancer 32: 369-370
2. Diasio RB, Beavers TL and Carpenter JT (1988) Familial deficiency of dihydropyrimidine dehydrogenase. J Clin Invest 81: 47-51
3. Etienne MC, Lagrange JL, Dassonville O, Fleming R, Thyss A, Renee N. Schneider M, Demard F and Milano G (1994) Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol 12: 2248-2253
4. Fleming RA, Milano GA, Thyss A, Etienne M-C, Renee N. Schneider M and Demard F (1992) Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res 52: 2899-2902
5. Harris BE, Carpenter JT and Diasio RB (1991) Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome. Cancer 68: 499-501
6. Heggie GD, Sommadossi J-P, Cross DS, Huster WJ and Diasio RB (1987) Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile. Cancer Res 47: 2203-2206
7. Hoyau P, Gray C, Chatelut E, Canal P, Roche H and Milano G (1993) Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency. J Natl Cancer Inst 85: 1602-1603
8. Lu Z-H, Zhang R and Diasio RB (1993) Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implications in 5-fluorouracil chemotherapy. Cancer Res 53: 5433-5438
9. Lyss AP, Lilenbaum RC, Harris BE and Diasio RB (1993) Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity. Cancer Invest 11: 239-240
10. McMurrough J and McLeod HL (1996) Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population. Br J Clin Pharmacol 41: 425-427
11. Milano G and Etienne M-C (1996) Individualising therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: theory and limits. Ther Drug Monit 18: 335-340
12. Takimoto CH, Lu Z-H, Zhang R, Liang MD, Larson LV, Cantilena LR, Grem JL, Allegra CJ, Diasio RB and Chu E (1996) Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res 2: 477-481
13. Vreken P, Van Kuilenburg ABP, Meinsma R, Smit GPA, Bakker HD, De Abreu RA and Van Gennip AH (1996) A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inher Metab Dis 19: 645-654
14. Wei X, McLeod HL, McMurrough J, Gonzalez FJ and Fernandez-Salguero P (1996). Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J Clin Invest 98: 610-615
15. Yokota H, Fernandez-Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD and Gonzalez FJ (1994) cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria. J Biol Chem 269: 23192-23196